Skip to main content
SpringerLink
Log in

An hypothesis on the role of glucose in the mechanism of action of cognitive enhancers

  • Review
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

This review presents evidence that some cognition enhancing drugs produce their beneficial effects on learning and memory by increasing the availability of glucose for uptake and utilization into the brain. The hypothesis further suggests that many cognition enhancing drugs act through a peripheral mechanism rather than directly on the brain. The general hypothesis is supported by four independent and converging pieces of evidence: 1) Some cognition enhancing drugs may not cross the blood-brain barrier, but can still facilitate memory; 2) Some cognition enhancing drugs are effective only when injected peripherally, but not when injected directly into the brain; 3) Many cognition enhancing drugs are not effective after adrenalectomy; 4) Cognitive function is correlated with glucose regulation in aged animals and humans. These four lines of research have implications for the role of glucose in the action of specific cognitive enhancers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Arnsten AFT, Segal DS, Nevile HJ, Hillyard SA, Janowsky DS, Judd LL, Bloom FE (1983) Naloxone augments electrophysiological signs of attention in man. Nature 304:725–727

    Google Scholar 

  • Bartus RT, Dean RL, Beer B, Lippa AS (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217:408–417

    Google Scholar 

  • Beani LC, Bianchi C, Giacomelli A, Tamberi F (1978) Noradrenaline inhibition of acetylcholine release from guinea-pig brain. Eur J Pharmacol 48:179–193

    Google Scholar 

  • Blass JP, Gibson GE (1979) Carbohydrates and acetylcholine synthesis: implications for cognitive discorders. In: Davis KL, Berger PA (eds) Brain acetylcholine and neuropsychiatric disease. Plenum Press, New York, pp 89–101

    Google Scholar 

  • Borell J, De Kloet ER, Versteeg DHG, Bohus B (1983) The role of adrenomedullary catecholamines in the modulation of memory by vasopressin. Dev Neurosci 16:85–90

    Google Scholar 

  • Borson S, Barnes RF, Veith RC, Halter JB, Raskind MA (1989) Impaired sympathetic nervous system response to cognitive effort in early Alzheimer's disease. J Gerontol 44:M8–M12

    Google Scholar 

  • Brioni JD, McGaugh JL (1989) Post-training administration of gabaergic antagonists enhances retention of aversively motivated tasks. Psychopharmacology (in press)

  • Caldwell DF (1962) Effects of adrenal demedullation on retention of a conditioned avoidance response in the mouse. J Comp Physiol Psychol 55:1079–1081

    Google Scholar 

  • Carr GD, White NM (1984) The relationship between stereotypy and memory improvement produced by amphetamine. Psychopharmacology 82:203–209

    Google Scholar 

  • Castellano C (1974) Cocaine, pemoline and amphetanine effects on learning and retention of a discrimination test in mice. Psychopharmacologia 36:67–76

    Google Scholar 

  • Conner RL, Levine S (1969) The effects of adrenal hormones on the acquisition of signaled avoidance behavior. Horm Behav 1:73–83

    Google Scholar 

  • Cooper JR, Bloom FE, Roth RH (1986) The biochemical basis of neuropharmacology. Oxford University Press, New York

    Google Scholar 

  • Davies P, Maloney AJR (1976) Selective loss of central cholinergic neurons in Alzheimer's disease (Letter). Lancet II:1403

    Google Scholar 

  • De Almeida MAMR, Kepczinski FP, Izquierdo I (1983) Memory modulation by post-training intraperitoneal, but not intracerebroventricular, administration of ACTH or epinephrine. Behav Neural Biol 39:277–283

    Google Scholar 

  • Doty B, Doty L (1966) Facilitating effects of amphetamine on avoidance conditioning in relation to age and problem difficulty. Psychopharmacologia 9:234–241

    Google Scholar 

  • Doty RL, Ferguson-Segall M (1987) Odor detection performance of rats followingd-amphetamine treatment: a signal detection analysis. Psychopharmacology 93:87–93

    Google Scholar 

  • Ettenberg A, Van Der Kooy D, Le Moal M, Koob GF, Bloom FE (1983) Can aversive properties of (peripherally-injected) vasopressin account for its putative role in memory? Behav Brain Res 7:331–350

    Google Scholar 

  • Evangelista AM, Izquierdo L (1971) The effect of pre-and post-trial amphetamine injections on avoidance responses in rats. Psychopharmacologia 20:42–47

    Google Scholar 

  • Fisman M, Gordon B, Feleki V, Helmes E, McDonald T, Dupre J (1988) Metabolic changes in Alzheimer's disease. J Am Geriatr Soc 36:298–300

    Google Scholar 

  • Fulginitti S, Cancela LM (1983) Effect of naloxone and amphetamine on acquisition and memory consolidation of active avoidance responses in rats. Psychopharmacology, 79:45–48

    Google Scholar 

  • Gallagher M (1982) Naloxone enhancement of memory processes: effects of other opiate antagonists. Behav Neural Biol 35:375–382

    Google Scholar 

  • Giurgea C (1976) Piracetam: nootropic pharmacology of neurointegrative activity. Curr Dev Psychopharmacol 3:221–276

    Google Scholar 

  • Giurgea C, Salama M (1977) Nootropic drugs. Neuropsychopharmacology 1:235–247

    Google Scholar 

  • Glick SD, Jarvik ME (1969) Impairment byd-amphetamine of delayed matching performance in monkeys. J Pharmacol Exp Ther 169:1–6

    Google Scholar 

  • Gold PE (1986) Glucose modulation of memory storage processing. Behav Neural Biol 45:342–349

    Google Scholar 

  • Gold PE, van Buskirk RB (1976) Enhancement and impairment of memory processes with post-trial injections of adrenocorticotrophic hormone. Behav Biol 16:387–400

    Google Scholar 

  • Gold PE, McGaugh JL (1977) Hormones and memory. In: Miller LH, Sandman CA, Kastin AJ (eds) Neuropeptide influences on the brain and behavior. Raven Press, New York, pp 127–143

    Google Scholar 

  • Gold PE, Stone WS (1988) Neuroendocrine effects on memory in aged rodents and humans. Neurobiol Aging 9:709–717

    Google Scholar 

  • Gold PE, Vogt J, Hall JL (1986) Glucose effects on memory behavioral and pharmacological characteristics. Behav Neural Biol 46:145–155

    Google Scholar 

  • Hall JL, Gold PE (1986) The effects of training, epinephrine, and glucose injection on plasma glucose levels in rats. Behav Neural Biol 46:156–167

    Google Scholar 

  • Hall JL, Gonder-Frederick L, Vogt J, Chewning WW, Silveira JA, Gold PE (1989) Memory enhancement in aged humans: effects of glucose ingestion. Neuropsychologia (in press)

  • Heise GA (1987) Facilitation of memory and cognition by drugs. TIPS 8:65–68

    Google Scholar 

  • Hertz MM, Paulson OB, Barry DI, Christiansen JS, Svendsen PA (1981) Insulin increases glucose transfer across the blood-brain barrier. J Clin Invest 67:597–604

    Google Scholar 

  • Hoyer S, Oesterreich K, Wager O (1988) Glucose metabolism as the site of the primary abnormality in early onset dementia of Alzheimer's type? J Neurol 235:143–148

    Google Scholar 

  • Introini-Collison IB, McGaugh JL (1988) Modulation of memory by post-training epinephrine: involvement of cholinergic mechanisms. Psychopharmacology, 94:379–385

    Google Scholar 

  • Introini I, McGaugh JL, Baratti CM (1985) Pharmacological evidence of a central effect of naltrexone, morphine, and betaendorphin and a peripheral effect of Met-and Leu-enkephalin on retention of an inhibitory response in mice. Behav Neural Biol 44:434–446

    Google Scholar 

  • Izquierdo I (1979) Effect of naloxone and morphine on various forms of memory in the rat: possible role of endogenous opiate mechanisms in memory consolidation. Psychopharmacology 66:199–203

    Google Scholar 

  • James DTD (1975) Post-triald-amphetamine sulfate and one-trial learning in mice. J Comp Physiol Psychol 89:626–635

    Google Scholar 

  • Johnson FN, Waite K (1971) Apparent delayed enhancement of memory following post-trial methylamphetamine HCl. Experientia 27:1316–1317

    Google Scholar 

  • Koob GF, Dantzer R, Rodriguez F, Bloom FE, Le Moal M (1985) Osmotic stress mimics effects of vasopressin on learned behavior. Nature 315:750–752

    Google Scholar 

  • Koob GF, Dantzer R, Bluthe R-M, Le Brun C, Bloom FE, Le Moal M (1986) Central injections of arginine vasopressin prolong extinction of active avoidance. Peptides 7:213–218

    Google Scholar 

  • Kovacs GL, Bohus B, Versteeg DHG (1979) Facilitation of memory consolidation by vasopressin: mediation by terminals of the dorsal noradrenergic bundle? Brain Res 172:73–85

    Google Scholar 

  • Kyriakis JM, Hausman RE, Peterson SW (1987) Insulin stimulates choline acetyltransferase activity in cultured embryonic chicken retina neurons. Proc Natl Acad Sci USA 84:7463–7467

    Google Scholar 

  • Le Brun CJ, Rigter H, Martinez JL, Koob GF, Le Moal M, Bloom FE (1984) Antagonism of effects of vasopressin (AVP) on inhibitory avoidance by a vasopressin antagonist peptide [dPtyr-(Me)AVP]. Life Sci 35:1505–1512

    Google Scholar 

  • Lee MK, Graham SN, Gold PE (1988) Memory enhancement with posttraining intraventricular glucose injections in rats. Behav Neurosci 102:591–595

    Google Scholar 

  • Le Moal M, Koob GF, Koda LY, Bloom FE, Manning M, Sawyer WH, Rivier J (1981) Vasopressor receptor antagonist prevents behavioral effects of vasopressin. Nature 291:491–493

    Google Scholar 

  • Levine S, Holiday S (1962) An effect of adrenal demedullation on the acquisition of a conditioned avoidance response. J Comp Physiol Psychol 55:214–216

    Google Scholar 

  • Liang KC, McGaugh JL (1983) Lesions of the stria terminalis attenuate the enhancing effect of post-training epinephrine on retention of an inhibitory avoidance response. Behav Brain Res 9:49–58

    Google Scholar 

  • Ljungberg T, Enquist M (1987) Disruptive effects of low doses ofd-amphetamine on the ability of rats to organize behavior into functional sequences. Psychopharmacology 93:146–151

    Google Scholar 

  • Martinez JL (1986) Memory: drugs and hormones. In: Martinez JL, Kesner RP (eds) Learning and memory: a biological view. Academic Press, Orlando, pp 127–163

    Google Scholar 

  • Martinez JL, de Graaf JS (1985) Quaternary naloxone enhances acquisition of a discriminated Y-maze escape and a one-way active avoidance task in mice. Psychopharmacology 87:410–413

    Google Scholar 

  • Martinez JL, Rigter H (1982) Enkephalin actions on avoidance conditioning may be related to adrenal medullary function. Behav Brain Res 6:289–299

    Google Scholar 

  • Martinez JL, Jensen RA, Messing RB, Vasquez BJ, Soumireu-Mourat B, Geddes D, Liang KC, McGaugh JL (1980a) Central and peripheral actions of amphetamine on memory storage. Brain Res 182:157–166

    Google Scholar 

  • Martinez JL, Vasquez BJ, Rigter H, Messing RB, Jensen RA, Liang KC, McGaugh JL (1980b) Attenuation of amphetamine-induced enhancement of learning. Brain Res 195:433–443

    Google Scholar 

  • Martinez JL, Jensen RA, McGaugh JL (1981) Attenuation of experimentally-induced amnesia. Prog Neurobiol 16:155–186

    Google Scholar 

  • Martinez JL, Ishikawa K, Liang KC, Jensen RA, Bennett C, Sternberg DB, McGaugh JL (1983) 4-OH Amphetamine enhances retention of an active avoidance response in rats and decreases regional brain concentrations of norepinephrine and dopamine. Behav Neurosci 97:969

    Google Scholar 

  • Martinez JL, Schulteis G, Janak PH, Weinberger SB (1988) Behavioral assessment of forgetting in aged rodents and its relationship to peripheral sympathetic function. Neurobiol Aging 9:697–708

    Google Scholar 

  • McGaugh JL (1973) Drug facilitation of learning and memory. Ann Rev Pharmacol Toxicol 13:229–241

    Google Scholar 

  • Meck WH, Church RM, Olton DS (1984) Hippocampus, time, and memory. Behav Neurosci 98:3–12

    Google Scholar 

  • Meck WH, Church RM, Wenk GL (1986) Arginine vasopressin innoculates against age-related increases in sodium-dependent high affinity choline uptake and discrepancies in the content of temporal memory. Eur J Pharmacol 130:327–331

    Google Scholar 

  • Messing RB, Jensen RA, Martinez JL Jr, Speihler VR, Vasquez BJ, Soumireu-Mourat B, Liang KC, McGaugh JL (1979) Naloxone enhancement of memory. Behav Neural Biol 27:266–275

    Google Scholar 

  • Mohs RC, Davis BM, Johns CA, Mathe AA, Greenwald BS, Horvath TB, Davis KL (1985) Oral physostigmine treatment of patients with Alzheimer's disease. Am J Psychiatry 142:28–33

    Google Scholar 

  • Mondadori C, Petschke F (1987) Do piracetam-like compounds act centrally via peripheral mechanisms? Brain Res 435:310–314

    Google Scholar 

  • Mondadori C, Classen W, Borkowski J, Ducret T, Buerki H, Schade A (1986) The effects of oxiracetam on learning and memory in animals. Comparison to piracetam. Neuropharmacology 7:27–38

    Google Scholar 

  • Morilak DC, Fornal C, Jacobs B (1987) Effects of physiological manipulations on locus coeruleus neuronal activity in freely moving cats. III. Gluco-regulating challenge. Brain Res 422:32–39

    Google Scholar 

  • Moyer KE, Bunnell BN (1959) Effect of adrenal demedullation on an avoidance response in the rat. J Comp Physiol Psychol 62:215–216

    Google Scholar 

  • Murray CL, Fibiger HC (1986) The effect of pramiracetam (CI-879) on the acquisition of a radial arm maze task. Psychopharmacology 89:378–381

    Google Scholar 

  • Orsingher OA, Fulginitti S (1971) Effects of alpha-methyl-tyrosine and adrenergic blocking agents on the facilitating action of amphetamine and nicotine on learning in rats. Psychopharmacology 19:213–240

    Google Scholar 

  • Orsingher OA, Fulginitti S (1973) Influence of peripheral mechanisms on the facilitatory learning action of amphetamine and nicotine. Pharmacology 9:138–144

    Google Scholar 

  • Piercey MF, Vogelsang GD, Franklin SR, Tang AH (1987) Reversal of scopolamine-induced amnesia and alterations in energy metabolism by the nootropic piracetam: implications regarding identification of brain structures involved in consolidation of memory traces. Brain Res 424:1–9

    Google Scholar 

  • Pugsley TA, Shih YH, Coughenour L, Stewart SF (1983) Some neurochemical properties of pramiracetam (Cl-879), a new cognition-enhancing agent. Drug Dev Res 3:407–420

    Google Scholar 

  • Reisberg B, Ferris SH, Anand R, Pervez Mir MA, Geibel V, de Leon MJ, Roberts E (1983) Effects of naloxone in senile dementia: a double-blind trial. N Engl J Med 308:721–722

    Google Scholar 

  • Riekkinen P, Legros J-J, Senner C, Jolkkonen J, Smitz S, Soininen H (1987) Penetration of DGAVP (Org 5667) across the blood-brain barrier in human subjects. Peptides 8:261–265

    Google Scholar 

  • Sahgal A (1987) Contrasting effects of vasopressin, desglycinamide-vasopressin and amphetamine on a delayed matching to position in rats. Psychopharmacology 93:243–249

    Google Scholar 

  • Sansone M, Castellan C, Ammassari-Teule M (1985) Improvement of avoidance acquisition by the nootropic drug oxiracetam in mice. Arch Int Pharmacodyn 275:86–92

    Google Scholar 

  • Sara SJ (1988) Glucose effects on firing rate of neurons of the locus coeruleus: another attempt to put memory back in the brain. Neurobiol Aging 9:31–33

    Google Scholar 

  • Sara SJ, Deweer B (1982) Memory retrieval enhanced by amphetamine after a long retention interval. Behav Neural Biol 36:146–160

    Google Scholar 

  • Sara SJ, Farnett J, Toussaint P (1982) Facilitation of appetitive brightness discrimination learning by lysine vasopressin. Behav Proc 7:157–167

    Google Scholar 

  • Schindler U, Rush DK, Fielding S (1984) Nootropic drugs: animal models for studying effects on cognition. Drug Dev Res 4:567–576

    Google Scholar 

  • Serota R, Roberts R, Flexner L (1972) Acetoxycycloheximide-induced transient amnesia: protective effects of adrenergic stimulants. Proc Natl Acad Sci USA 69:340–342

    Google Scholar 

  • Silva MTA (1974) Extinction of a passive avoidance response in adrenalectomized and demedullated rats. Behav Biol 9:553–567

    Google Scholar 

  • Sloviter RS, Valiquette G, Abrams GM, Ronk EC, Sollas AL, Paul LA, Neubort S (1989) Selective loss of hippocampal granule cells in the mature rat brain after adrenalectomy. Science 243:535–538

    Google Scholar 

  • Spignoli G, Pepeu G (1987) Interactions between oxiracetam, aniracetam and scopolamine on behavior and brain acetylcholine. Pharmacol Biochem Behav 27:491–495

    Google Scholar 

  • Stone WS, Cottrill KL, Gold PE (1987) Glucose and epinephrine attenuation of scopolamine induced increases in locomotor activity in mice. Neurosci Res Commun 1:105–111

    Google Scholar 

  • Stone WS, Croul CE, Gold PE (1989) Attenuation of scopolamide induced amnesia in mice. Psychopharmacology (in press)

  • Summers WK, Majovski LV, Marsh GM, Tachiki K, Kling A (1986) Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer's type (Letter). N Engl J Med 316:1605–1609

    Google Scholar 

  • Tyce GM, Wong KL (1983) Glucose and amino acid metabolism in rat brain during sustained hypoglycemia. Neurochem Res 8:401–415

    Google Scholar 

  • Vincent G, Verderese A, Gamzu A (1985) The effects of aniracetam (RO 13-5057) on the enhancement and protection of memory. Ann NY Acad Sci 444:489–491

    Google Scholar 

  • Weldon DA, Wool RS, Teicher MH, Shaywitz BA, Cohen DJ, Anderson GM (1982) Effects of apomorphine on appetitive conditioning in 6-hydroxydopamine treated rat pups. Pharmacol Biochem Behav 17:1281–1284

    Google Scholar 

  • Wenk GL, Grey CM, Ingram DK, Spangler EL, Olton DS (1989) Retention of maze performance inversely correlates with NMDA receptor number in hippocampus and frontal neocortex in rat. Behav Neurosci (in press)

  • Wenk GL, Olton DS (1989) Cognitive enhancers: potential strategies and experimental results. Prog Neuropsychopharmacol Biol Psychiatry (in press)

  • White NM, Messier C (1988) Effects of adrenal demedullation on conditioned emotional response and on the memory impoving action of glucose. Behav Neurosci 102:499–503

    Google Scholar 

  • Wied D de, van Ree JM (1982) Neuropeptides, mental performance and aging. Life Sci 31:709–719

    Google Scholar 

  • Wimersma Greidanus TB van, van Ree JM, de Weid D (1983) Vasopressin and memory. Pharmacol Ther 20:437–458

    Google Scholar 

  • Wolthuis OL (1971) Experiments with UCB 6215, a drug which enhances acquisition in rats: its effects compared with those of metamphetamine. Eur J Pharmacol 16:283–297

    Google Scholar 

  • Wool RS, Weldon DA, Shaywitz BA, Anderson GM, Cohen DJ, Teicher MH (1987) Amphetamine reverses learning deficits in 6-hydroxydopamine-treated rat pups. Dev Psychobiol 20:219–232

    Google Scholar 

  • Wurtman RJ, Magil SG, Reinstein DK (1981) Piracetam diminishes hippocampal ACh levels in rats. Life Sci 28:1091–1093

    Google Scholar 

  • Zhang S, McGaugh JL, Juler RG, Introini-Collison IB (1987) Naloxone and [Met5]enkephalin effects on retention: attenuation by adrenal denervation. Eur J Pharmacol 138:37–44

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neuromnemonics Laboratory, Department of Psychology, Johns Hopkins University, 21218, Baltimore, MD, USA

    Gary L. Wenk

Authors
  1. Gary L. Wenk
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wenk, G.L. An hypothesis on the role of glucose in the mechanism of action of cognitive enhancers. Psychopharmacology 99, 431–438 (1989). https://doi.org/10.1007/BF00589888

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00589888

Key words

Search

Navigation